Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

360 Spotlight: IN8BIO (INAB)

360 Spotlight: IN8BIO (INAB)

FromSchwab Network


360 Spotlight: IN8BIO (INAB)

FromSchwab Network

ratings:
Length:
7 minutes
Released:
Oct 14, 2021
Format:
Podcast episode

Description

IN8BIO (INAB) is a clinical-stage biopharmaceutical company focused on therapies for the treatment of cancers. William Ho, President, CEO, and Co-Founder of IN8BIO, discusses the company and how IN8BIO went public via IPO on July 30th. He also talks about how IN8BIO develops gamma-delta T-cell therapies for the treatment of cancer. Tune in to find out more.
Released:
Oct 14, 2021
Format:
Podcast episode

Titles in the series (100)

A unique lineup of financial news and education programs, all available to stream without a subscription. Listen to industry experts track market action and interpret how it may apply to your investment portfolio. Get real-time insights, commentary, and exclusive access to CEOs, analysts, and market experts. Empowering Every Investor and Trader. Every Market Day. Produced by TD Ameritrade Media Productions Company, a wholly-owned subsidiary of TD Ameritrade Holding Corporation. TD Ameritrade Holding Corporation is a wholly owned subsidiary of The Charles Schwab Corporation. TD Ameritrade Media Productions Company is not a financial adviser, registered investment advisor, or broker-dealer. THE TD AMERITRADE NETWORK SITE, CONTENT, APPS, AND RELATED SERVICES, ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED. This is not an offer or solicitation in any jurisdiction where we are not authorized to do business or where such offer or solicitation would be contrary to the local laws and regulations of that jurisdiction, including, but not limited to persons residing in Australia, Canada, Japan, Saudi Arabia, UK, and the countries of the European Union. All TD Ameritrade Network content © TD Ameritrade Network. All rights reserved.